How to Train Your Oncolytic Virus: The Immunological Sequel

被引:6
作者
Vile, Richard G. [1 ,2 ,3 ]
机构
[1] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA
[3] St James Univ Hosp, Canc Res UK Clin Ctr, Leeds LS9 7TF, W Yorkshire, England
关键词
CANCER; IMMUNOTHERAPY; CTLA-4; REMISSION; DELIVERY; BLOCKADE; PD-L1;
D O I
10.1038/mt.2014.188
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:1881 / 1884
页数:4
相关论文
共 25 条
[1]   Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans [J].
Breitbach, Caroline J. ;
Burke, James ;
Jonker, Derek ;
Stephenson, Joe ;
Haas, Andrew R. ;
Chow, Laura Q. M. ;
Nieva, Jorge ;
Hwang, Tae-Ho ;
Moon, Anne ;
Patt, Richard ;
Pelusio, Adina ;
Le Boeuf, Fabrice ;
Burns, Joe ;
Evgin, Laura ;
De Silva, Naomi ;
Cvancic, Sara ;
Robertson, Terri ;
Je, Ji-Eun ;
Lee, Yeon-Sook ;
Parato, Kelley ;
Diallo, Jean-Simon ;
Fenster, Aaron ;
Daneshmand, Manijeh ;
Bell, John C. ;
Kirn, David H. .
NATURE, 2011, 477 (7362) :99-U102
[2]   Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded [J].
Cattaneo, Roberto ;
Miest, Tanner ;
Shashkova, Elena V. ;
Barry, Michael A. .
NATURE REVIEWS MICROBIOLOGY, 2008, 6 (07) :529-540
[3]   Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4 [J].
Dias, J. D. ;
Hemminki, O. ;
Diaconu, I. ;
Hirvinen, M. ;
Bonetti, A. ;
Guse, K. ;
Escutenaire, S. ;
Kanerva, A. ;
Pesonen, S. ;
Loskog, A. ;
Cerullo, V. ;
Hemminki, A. .
GENE THERAPY, 2012, 19 (10) :988-998
[4]  
Donnelly OG, 2012, CURR PHARM BIOTECHNO, V13, P1834
[5]   Live viruses to treat cancer [J].
Donnelly, Oliver ;
Harrington, Kevin ;
Melcher, Alan ;
Pandha, Hardev .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2013, 106 (08) :310-314
[6]   CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy [J].
Engeland, Christine E. ;
Grossardt, Christian ;
Veinaide, Ruta ;
Bossow, Sascha ;
Lutz, Diana ;
Kaufmann, Johanna K. ;
Shevchenko, Ivan ;
Umansky, Viktor ;
Nettelbeck, Dirk M. ;
Weichert, Wilko ;
Jaeger, Dirk ;
von Katie, Christof ;
Ungerechts, Guy .
MOLECULAR THERAPY, 2014, 22 (11) :1949-1959
[7]   Oncolytic immunotherapy: dying the right way is a key to eliciting potent antitumor immunity [J].
Guo, Zong Sheng ;
Liu, Zuqiang ;
Bartlett, David L. .
FRONTIERS IN ONCOLOGY, 2014, 4
[8]   Improved Survival with Ipilimumab in Patients with Metastatic Melanoma [J].
Hodi, F. Stephen ;
O'Day, Steven J. ;
McDermott, David F. ;
Weber, Robert W. ;
Sosman, Jeffrey A. ;
Haanen, John B. ;
Gonzalez, Rene ;
Robert, Caroline ;
Schadendorf, Dirk ;
Hassel, Jessica C. ;
Akerley, Wallace ;
van den Eertwegh, Alfons J. M. ;
Lutzky, Jose ;
Lorigan, Paul ;
Vaubel, Julia M. ;
Linette, Gerald P. ;
Hogg, David ;
Ottensmeier, Christian H. ;
Lebbe, Celeste ;
Peschel, Christian ;
Quirt, Ian ;
Clark, Joseph I. ;
Wolchok, Jedd D. ;
Weber, Jeffrey S. ;
Tian, Jason ;
Yellin, Michael J. ;
Nichol, Geoffrey M. ;
Hoos, Axel ;
Urba, Walter J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) :711-723
[9]   Cytokine Conditioning Enhances Systemic Delivery and Therapy of an Oncolytic Virus [J].
Ilett, Elizabeth ;
Kottke, Timothy ;
Donnelly, Oliver ;
Thompson, Jill ;
Willmon, Candice ;
Diaz, Rosa ;
Zaidi, Shane ;
Coffey, Matt ;
Selby, Peter ;
Harrington, Kevin ;
Pandha, Hardev ;
Melcher, Alan ;
Vile, Richard .
MOLECULAR THERAPY, 2014, 22 (10) :1851-1863
[10]   History of oncolytic viruses: Genesis to genetic engineering [J].
Kelly, Elizabeth ;
Russell, Stephen J. .
MOLECULAR THERAPY, 2007, 15 (04) :651-659